Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 28
3
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Birds eavesdrop on plant indirect defenses to locate insect preys

We all know that birds have a great vision, right? But what if they could also smell?! We demonstrated...

Where are all the Diamondback terrapins on Cumberland Island?

There is no previous population study that exists on the Diamondback terrapins of Cumberland Island, Georgia...

Transforming Styrofoam waste into biodegradable plastic

The primary objective of the project is to create an industrially-comparable method of producing PHA, a...

Backer Badge Funded